Boon Industries Inc.

Boon Completes Phase-I of EPA Testing of DIOX+ $25M Revenue on Horizon

Mar 1, 2021


SACRAMENTO, CA, Mar. 1, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BOON Industries (OTC PINK:BNOW) (“BOON” or the “Company”), announces that the company has completed Phase-I of its EPA testing of its DIOX+.

Justin Gonzalez, CEO, stated, “Boon will complete its Form-10 Filing and Audit to go SEC Fully-Reporting this month, which will coincide with up-listing to the OTCQB. A growing number of industries and near-future contracts are relying on the superior disinfection and environmentally-friendly properties of our DIOX+ product which they will use to not only disinfect municipal and drinking water supplies, but also control the water’s taste, odor and color. Our government and commercial contracts will utilize DIOX+ to sanitize complete warehouses, equipment and preparation surfaces, wash fruits and vegetables, and prevent salmonella and e-coli from contaminating meat and poultry.”

Boon is an environmentally conscious company, and DIOX+ is the first of many environmentally friendly products that outperforms common toxic and unsafe products currently in the market today. In fact, DIOX+ technology protects the environment and human health from bacteria and by-products formed by other disinfection methods. For example, in the pulp and paper industry, the use of ClO2 has virtually eliminated dioxin in mill wastewater and has led to significant improvements in surrounding ecosystems. As a result, the Federal government is phasing out the use of chlorine in pulp mills over the next few years.

DIOX+ is used to kill pathogenic microorganisms on the media to make them harmless, eliminate pathogenic microorganisms from the human body, cut off the transmission route of infectious diseases, and achieve the purpose of controlling infectious diseases. The commercial sanitization offers medical-grade disinfection, used for eliminating bacteria and viruses. It is used to reduce infectious disease in commercial places by the antibacterial coating of the fresh air system and treatment of atomization. It’s entirely safe for use in any workplace, even when employees or customers experience respiratory difficulties.

Boon has completed its new production facility in Northern California and will prepare to distribute DIOX+ to the global commercial sanitization market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The Asia Pacific is slated to account for a significant share by 2027 in the commercial sanitization market. The growth in the region can be attributed to the surge in demand for sanitizer from various industries such as manufacturing, healthcare, retail and foodservice, and automotive and aerospace, among others. Additionally, the swelling spending power of consumers in the region and the growing awareness about hygiene in these regions will spur the commercial sanitization market. North America is projected to provide significant growth opportunities due to the implementation of government initiatives and stringent regulations on sterilization and disinfection in working places such as hospitals, offices, shopping malls, etc.

Boon will target various sanitization leaders to provide distribution opportunities; such as UVD Robots (Denmark), OrionStar (China), Bioquell Plc. (United Kingdom), Blue Ocean Robotics Norway As (Norway), The Clorox Company (United States), Intellibot Robotics LLC (United States), IRobot Corporation (United States), Lumalier.


Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Investor Relations
The Cervelle Group
Dave Donlin
Boon Industries, Inc.